A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
Clinical trial NCT04712643 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04712643
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2029-02-01
- Enrollment
- 342
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.